Thursday, October 23, 2025
Industry NewsKodak moves into pharma backed by US$ 765 million...

Kodak moves into pharma backed by US$ 765 million Federal loan

-

Kodak moves into pharma backed by US$ 765 million Federal loan

-
Kodak moves into pharma

Eastman Kodak has signed a letter of intent for a $765 million US government loan with which it plans to begin production of critical active pharmaceutical ingredients (APIs) that the US now imports. The government loan will help support startup costs needed to repurpose and expand Kodak’s existing facilities in Rochester, New York, and St. Paul, Minnesota. Kodak Pharmaceuticals will make critical pharmaceutical ingredients that have been identified as essential but have lapsed into chronic national shortage, as defined by the Food and Drug Administration.

At the direction of US President Donald J Trump, US International Development Finance Corporation (DFC) chief executive officer Adam Boehler has signed a letter of interest (LOI) to provide the loan to Kodak to support the launch of Kodak Pharmaceuticals, a new arm of the company that will produce critical pharmaceutical components. The project would mark the first use of new authority delegated by President Trump’s recent executive order that enables DFC and the U.S. Department of Defense (DOD) to collaborate in support of the domestic response to COVID-19 under the Defense Production Act (DPA).

“Kodak is proud to be a part of strengthening America’s self-sufficiency in producing the key pharmaceutical ingredients we need to keep our citizens safe,” said Kodak Executive Chairman Jim Continenza. “By leveraging our vast infrastructure, deep expertise in chemicals manufacturing, and heritage of innovation and quality, Kodak will play a critical role in the return of a reliable American pharmaceutical supply chain.”

“Addressing the unprecedented challenges we face today—and preparing for future crises—requires innovative ideas and partnerships,” said Boehler. “Today, we are bringing together the significant resources and expertise of the private sector and US Government. We are pleased to support Kodak in this bold new venture. Our collaboration with this iconic American company will promote health and safety at home and around the world.”

Once fully operational, Kodak Pharmaceuticals will have the capacity to produce up to 25% of active pharmaceutical ingredients used in non-biologic, non-antibacterial, generic pharmaceuticals while supporting 360 direct jobs and an additional 1,200 indirectly. The company plans to coordinate closely with the Administration and pharmaceutical manufacturers to identify and prioritize components that are most critical to the American people and U.S. national security.

Mahan Hazarika
Mahan Hazarika
Mahan Hazarika assumes the role of Editor at The Packman, a position he has held since 2017, reflecting a distinguished decade-long tenure specializing in journalism within the printing and packaging sectors. Beyond his professional realm, he nurtures a deep appreciation for music, travel, and films, finding inspiration and relaxation in these pursuits.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Latest news

Heidelberg India signs MOU with Sri Kaliswari Group to launch MK Masterwork Demo and Training Center

On 15 October 2025, a Memorandum of Understanding was signed between Thomas Frank, managing director, Heidelberg Asia Pacific, and...

Asahi Photoproducts to host second AWP Environment Event at CIIE 2025 in Shanghai

Asahi Photoproducts, a leader in sustainable flexographic plate technology and a division of Asahi Kasei, will exhibit at the...

New president, vice-president, board members and re-elections at GRA

The Global Rotogravure Association (GRA) is pleased to announce the election of new officers and board members during its...

Amcor announces operational launch of new MDO line in Peru

Amcor, a global leader in developing and producing responsible packaging solutions, announced the installation and operational readiness of a...
- Advertisement -spot_img

Ranpak brings AI-driven packaging intelligence to Logistica Next 2025

Ranpak, a global leader of sustainable paper-based automated packaging solutions for e-commerce and industrial supply chains, will exhibit its...

London Packaging Week 2025 sees strong rise in visitors

London Packaging Week 2025 has recorded a 15% growth in attendance, attracting 5,752 unique visitors to Excel London. Now...

Must read

artience group to feature inkjet technology at drupa 2024

Toyo Ink Europe Specialty Chemicals, a member of the...

Media Expo introduces brand-new category on ‘labeling’

Messe Frankfurt India has introduced a brand-new category on...

You might also likeRELATED
Recommended to you